683 Capital Management’s iTeos Therapeutics ITOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,750,000
| Closed | -$10.4M | – | 130 |
|
|
2025
Q1 | $10.4M | Buy |
1,750,000
+831,883
| +91% | +$4.97M | 0.72% | 30 |
|
|
2024
Q4 | $7.05M | Sell |
918,117
-652,171
| -42% | -$5.01M | 0.44% | 45 |
|
|
2024
Q3 | $16M | Buy |
1,570,288
+455,288
| +41% | +$4.65M | 1.22% | 23 |
|
|
2024
Q2 | $16.5M | Buy |
1,115,000
+400,000
| +56% | +$5.94M | 1.25% | 18 |
|
|
2024
Q1 | $9.75M | Hold |
715,000
| – | – | 0.71% | 35 |
|
|
2023
Q4 | $7.83M | Sell |
715,000
-95,000
| -12% | -$1.04M | 0.64% | 44 |
|
|
2023
Q3 | $8.87M | Buy |
810,000
+225,000
| +38% | +$2.46M | 0.69% | 41 |
|
|
2023
Q2 | $7.75M | Buy |
585,000
+105,000
| +22% | +$1.39M | 0.56% | 40 |
|
|
2023
Q1 | $6.53M | Buy |
480,000
+330,000
| +220% | +$4.49M | 0.49% | 48 |
|
|
2022
Q4 | $2.93M | Buy |
+150,000
| New | +$2.93M | 0.25% | 81 |
|
|
2021
Q4 | – | Sell |
-200,413
| Closed | -$5.41M | – | 344 |
|
|
2021
Q3 | $5.41M | Buy |
+200,413
| New | +$5.41M | 0.21% | 70 |
|